By Gina Shaw
As federal officials explore possible strategic solutions to the ongoing problem of drug shortages, they are looking to leverage both 503A and 503B drug compounding facilities as potential avenues for filling in the gaps when a drug is in short supply, said legal experts at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.
OCTOBER 10, 2024